Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT01679990Phase 2Completed
Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)
Intermittent ClaudicationPeripheral Artery Disease
Principalinvestigator

Research Network

Collaboration Network

30 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Ajou University School of Medicine

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Stefan Betge, MD

Jena University Hospital

Related
1 trials

Shared therapeutic areas:

Intermittent ClaudicationPeripheral Arterial Disease

Worked with same sponsors:

Pluristem Ltd.
Collaborated on 1 trial
Similarity Score24%

Sungwon Chung, MD

Pusan National University Hospital 179 Gudeok-Ro Seo-Gu, Busan, 602-739, Korea

Related
1 trials

Shared therapeutic areas:

Intermittent ClaudicationPeripheral Arterial Disease

Worked with same sponsors:

Pluristem Ltd.
Collaborated on 1 trial
Similarity Score24%

Kwangjo Cho, MD

Dong-A University Hospital

Related
1 trials

Shared therapeutic areas:

Intermittent ClaudicationPeripheral Arterial Disease

Worked with same sponsors:

Pluristem Ltd.
Collaborated on 1 trial
Similarity Score24%

Holger Reinecke, MD

Universitätsklinikum Münster

Related
1 trials

Shared therapeutic areas:

Intermittent ClaudicationPeripheral Arterial Disease

Worked with same sponsors:

Pluristem Ltd.
Collaborated on 1 trial
Similarity Score24%

James Hampsey, MD

Tampa Bay Medical research, 3251 McMullen Booth Road, STE 303, Clearwater, FL 33761

Related
1 trials

Shared therapeutic areas:

Intermittent ClaudicationPeripheral Arterial Disease

Worked with same sponsors:

Pluristem Ltd.
Collaborated on 1 trial
Similarity Score24%

Dokyun Kim, MD

National Health Insurance Service Ilsan Hospital

Related
1 trials

Shared therapeutic areas:

Intermittent ClaudicationPeripheral Arterial Disease

Worked with same sponsors:

Pluristem Ltd.
Collaborated on 1 trial
Similarity Score24%

Sigrid Nikol, MD

ASKLEPIOS Klinik St. Georg, Hamburg Germany

Related
1 trials

Shared therapeutic areas:

Intermittent ClaudicationPeripheral Arterial Disease

Worked with same sponsors:

Pluristem Ltd.
Collaborated on 1 trial
Similarity Score24%

Reuven Zimlichman, MD

Edith Wolfson Medical Center,62 HaLohamim Street, Holon, Israel

Related
1 trials

Shared therapeutic areas:

Intermittent ClaudicationPeripheral Arterial Disease

Worked with same sponsors:

Pluristem Ltd.
Collaborated on 1 trial
Similarity Score24%

Norbert Weiss, MD

Universitätsklinikum Carl Gustav Carus, Dresden, Germany

Related
1 trials

Shared therapeutic areas:

Intermittent ClaudicationPeripheral Arterial Disease

Worked with same sponsors:

Pluristem Ltd.
Collaborated on 1 trial
Similarity Score24%

Weonyong Lee, MD

Hallym University Sacred Heart Hospital 22, Gwanpyeong-ro 170beon-gil, Dongan-gu, Anyang-si, Gyeonggi-do, 431-796, Korea

Related
1 trials

Shared therapeutic areas:

Intermittent ClaudicationPeripheral Arterial Disease

Worked with same sponsors:

Pluristem Ltd.
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01679990Phase 2PrincipalInvestigator

Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

Intermittent ClaudicationPeripheral Artery Disease
Completed

All 1 trials loaded